HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells
Previous studies in mice and humans have suggested an important role for CD8+ T cells in host defense to Mtb. Recently, we have described human, Mtb-specific CD8+ cells that are neither HLA-A, B, or C nor group 1 CD1 restricted, and have found that these cells comprise the dominant CD8+ T cell respo...
Saved in:
Published in | The Journal of experimental medicine Vol. 196; no. 11; pp. 1473 - 1481 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Rockefeller University Press
02.12.2002
The Rockefeller University Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Previous studies in mice and humans have suggested an important role for CD8+ T cells in host defense to Mtb. Recently, we have described human, Mtb-specific CD8+ cells that are neither HLA-A, B, or C nor group 1 CD1 restricted, and have found that these cells comprise the dominant CD8+ T cell response in latently infected individuals. In this report, three independent methods are used to demonstrate the ability of these cells to recognize Mtb-derived antigen in the context of the monomorphic HLA-E molecule. This is the first demonstration of the ability of HLA-E to present pathogen-derived antigen. Further definition of the HLA-E specific response may aid development of an effective vaccine against tuberculosis. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Address correspondence to David Lewinsohn, Pulmonary & CCM, PVAMC/OHSU, R&D 11, 3710 SW US Veterans Rd., Portland, OR 97201. Phone: 503-721-1020; Fax: 503-402-2816; E-mail: lewinsod@ohsu.edu This work has been presented in part at the ASM Conference on Immunity to Bacterial, Viral, and Protozoal Pathogens, March 20–24, 2002, in Savannah, GA, the American Thoracic Society, May 17–22, 2002, in Atlanta, GA, and the Fourth World Congress on TB, June 3–5, 2002, in Washington, D.C. |
ISSN: | 0022-1007 1540-9538 |
DOI: | 10.1084/jem.20020609 |